[compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. ( CSP )]
UMLS (CSP) C0014432 Relation/PAR: inhibitor/antagonist
Enzyme Interaction
Relation/CHD: carbonic anhydrase inhibitor
PAI
protease inhibitor
(5alpha,17beta)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
cyclooxygenase inhibitor
kininogen
(+)-(4S)-4,11-diethyl-4-hydroxy-9-[(4-piperidino-piperidino)carbonyloxy]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinol-3,14,(4H,12H)-dione
(-)-2-(2-Chlorophenyl)-5,7-dihydroxy-8-[(3R,4S)-3-hydroxy-1-methyl-4-piperidinyl]-4H-1-benzopyran-4-one Hydrochloride
Reverse Transcriptase Inhibitor
CDK-Interacting Protein 1
decarboxylase inhibitor
Androstenedione Aromatase Inhibitor
esterase inhibitor
oxidoreductase inhibitor
phosphatase inhibitor
phospholipase inhibitor
kinase inhibitor
antithrombin
carbonic anhydrase inhibitor
cholinesterase inhibitor
MAO inhibitor
Phosphodiesterase Inhibitor
protease inhibitor
Protein Synthesis Inhibitor
Lipoxygenase Inhibitors
cyclooxygenase inhibitor
HMG-CoA Reductase Inhibitor
Inhibitors, Nucleic Acid Synthesis
Integrase Inhibitors
amylase inhibitor
Plasmin Inhibitors
Lipase Inhibitors
alpha Glucosidase Inhibitors
5 Alpha-Reductase Inhibitor
beta Lactamase Inhibitors
Enkephalinase Inhibitors
Acetyl Aldehyde Dehydrogenase Inhibitors
Alcohol Dehyrogenase Inhibitors
Nitric Oxide Synthase Inhibitor
Vitamin K Epoxide Reductase Inhibitors
Uncouplers
Non-receptor Tyrosine Kinase Inhibitors
Sterol Synthesis Inhibitors
Platelet Activating Factor Inhibitors
Dephosphorylation Inhibitors
PABA Inhibitor
PBP inhibitors
Tissue Plasminogen Activator Inhibitors
Adenosine Diphosphate Receptor Inhibitors
Thyroid Peroxidase Inhibitors
Squalene Epoxidase Inhibitors
DNA Gyrase Inhibitors
Xanthine Oxidase Inhibitors